CASC2 and neoplasm: The results showed that CASC2 knockdown promoted the cell viability while TRAIL treatment suppressed the cell viability of HepG2R and Rel-7402R cell; the suppressive effect of TRAIL on tumor cell viability could be partially reversed by CASC2 knockdown (Fig.4a).